As of May 2026, the metabolomics community is witnessing a convergence of open-source database innovation and proprietary software intelligence. LIPID MAPS recently published a landmark focus article ...

For decades, Parkinson’s disease research focused almost exclusively on protein misfolding, but 2025-2026 lipidomics breakthroughs have upended this view by demonstrating that lipid droplets actively ...

Lipid nanoparticles address key drug delivery challenges, including immune evasion, toxicity, and regulatory approval.

Lipid nanoparticle formulation has increased over the past two decades. LNPs have proven to be effective nano-based delivery vehicles for cytotoxic chemotherapeutic drugs, nucleic acid therapies and ...

A review maps high throughput strategies that link automation, microfluidics, and barcoding into a unified pipeline, enabling faster, more predictive lipid nanoparticle development for genetic ...

Illustration of a dimer protein structure. A structure of the stimulator of interferon genes (STING) dimer shows how it binds to a phosphatidylinositol species. Credit: Nature The work suggests new ...

The skin is the largest organ of the body, and it plays a crucial role as the first line of defense against pathogens and insults from the external environment. It provides important functions like ...

Sepsis, a life-threatening condition caused by dysregulated host response to infection, remains a major cause of global ...

Lipid nanoparticles (LNPs) have emerged as a transformative platform in the field of neurotherapeutics, particularly for targeting the aging brain.